There is an investor call recording you can look up on their site from earlier today. Based on listening to that they seem to really have their shit together. 12 month supply already available, have initial orders that will ship on May 6th, they have distribution agreements with all 3 of the big medical distributors, sales teams set up and ready to roll, drug doesn’t require any special refrigeration so easy to store and use by care providers, etc. They sounded to me like they have their act together to become legit.
They probably all got deleted. To really dumb down mine - the stock has barely any institutional ownership and from digging around most “legit” pharma companies have around 70%. The float is tiny (mostly insider owned - close to 80%). If this drug moves them into he “legit” category from an institutional perspective then this has nowhere to go but up.
I’ll leave the squeeze chatter to others.
Well.. Earnings report is may 9th & they did just approved by the FDA for a cancer treating drug so that is in their favor. But do what you wish with this info, personally I might wait till 8 to sell but I’m also greedy with my +875% return today lol
I think people were initially worried that Anktiva would only be useful for a fraction of a small percentage of BC patients but the drug could be so much more influential for other types. Definitely Increases marketability substantially.